Note 4 - Other Financial Information

3 Months Ended

Mar. 31, 2026

Note 4 – Other Financial Information

Accounts Payable and Accrued Expenses

Accounts payable and accrued expenses consisted of the following as of March 31, 2026 and December 31, 2025 (in thousands):

	*March 31,*		*December 31,*
	*2026*		*2025*
Accounts payable	$	17,209	$	12,137
Accrued sales reserves		8,278		6,493
Accrued clinical expenses		2,627		2,364
Accrued research and development expenses		749		886
Accrued selling, general and administrative expenses		4,562		3,903
Accrued other expenses		1,921		1,934
Total accounts payable and accrued expenses	$	35,346	$	27,717

Interest and Other Income, Net

Interest and other income, net consisted of the following for the three months ended March 31, 2026 and 2025 (in thousands):

	*Three Months Ended March 31,*
	*2026*			*2025*
Interest income	$	931		$	2,204
Other loss, net		(323	)		(90	)
Total interest and other income, net	$	608		$	2,114